Table 2.
Treated according to treatment guidelines | ||||
---|---|---|---|---|
Total | Yes (n = 852) | No (n = 233) | ||
Characteristics | No. (Column %) | No. (Row %) | No. (Row %) | p-value* |
Tumour stage | 0.005 | |||
IA | 230 (21) | 175 (76) | 55 (24) | |
IB-IIA | 400 (37) | 301 (75) | 99 (25) | |
IIB-IVA | 435 (37) | 326 (75) | 109 (25) | |
IVB | 52 (5) | 50 (96) | 2 (4) | |
Age at diagnosis | 0.22 | |||
0–45 | 518 (48) | 398 (77) | 120 (23) | |
46–65 | 333 (31) | 261 (78) | 72 (22) | |
>65 | 234 (22) | 193 (82) | 41 (18) | |
Histology | 0.04 | |||
SCC | 866 (80) | 691 (80) | 175 (20) | |
Others | 219 (20) | 161 (74) | 58 (26) | |
Area of residence | 0.90 | |||
Urban | 707 (65) | 554 (78) | 153 (22) | |
Rural | 378 (35) | 298 (79) | 80 (21) | |
Diagnosis period | <.0001 | |||
1984–1998 | 718 (66) | 594 (83) | 124 (17) | |
1999–2008 | 367 (34) | 258 (70) | 109 (30) |
SCC squamous cell carcinoma/adenosquamous carcinoma
*For chi-square test of association
aAfter excluding cases with either missing stage data (14 %, mostly diagnosed in 2000–2003), cause of death (4 %) or treatment records (5 %)